Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2014-12-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Marketing of Alcohol Products on Young People
NCT03818750
Effect of Cognitive Training on Alcohol Use Outcomes
NCT02113618
Residual Effects of Intoxication on Student Performance
NCT00183170
Brain Responses to Contextual Influences on Drinking Decisions
NCT04895033
Influence of Alcohol Marketing Stimuli in Adults With Regular Alcohol Consumption
NCT05125783
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Beer (alcoholic) followed by placebo (non-alcoholic)
Cross-over within-subjects design with all treatment conditions tested in the same subject. This design has two treatment conditions in the same subject.
Beer (alcoholic)
Beer (individually calculated amount aiming to achieve a blood-alcohol-centration of 0.4g/kg)
Placebo (non-alcoholic beer)
Non-alcoholic beer serves as Placebo.
Placebo (non-acoholic beer) followed by Beer (alcoholic)
Cross-over within-subjects design with all treatment conditions tested in the same subject. This design has two treatment conditions in the same subject.
Beer (alcoholic)
Beer (individually calculated amount aiming to achieve a blood-alcohol-centration of 0.4g/kg)
Placebo (non-alcoholic beer)
Non-alcoholic beer serves as Placebo.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Beer (alcoholic)
Beer (individually calculated amount aiming to achieve a blood-alcohol-centration of 0.4g/kg)
Placebo (non-alcoholic beer)
Non-alcoholic beer serves as Placebo.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Sufficient understanding of the German language
3. Subjects understand the procedures and the risks associated with the study
4. Participants must be willing to adhere to the protocol and sign the consent form
5. Participants must be willing to refrain from drinking alcohol in the evening preceding the study session
6. Participants must be willing to abstain from excessive drinking and from taking illicit psychoactive drugs during the study.
7. Participants must be willing not to eat or drink xanthine-containing liquids (such as coffee, black or green tea, red bull, chocolate) 3 h prior to the study session
8. Participants must be willing not to drive a traffic vehicle or to operate machines for 3h after the sessions
9. Women must have a negative pregnancy test at the beginning of each session.
Exclusion Criteria
2. Current or previous personal history of psychotic or major affective disorder.
3. Prior or current alcohol abuse, dangerous drinking behavior (\>15 points in the AUDIT questionnaire).
4. Family history of alcoholism (first-degree relative).
5. Alcohol hypersensitivity
6. Prior illicit drug use (except Tetrahydrocannabinol (THC)-containing products) more than 15 times or any time within the previous week.
7. Use of medications that are contraindicated or interfere otherwise with the effects of the study (monoamine oxidase inhibitors, antidepressants, sedatives etc.)
8. Pregnant or nursing women.
9. Participation in another clinical trial (currently or within the last 30 days).
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthias E Liechti, MD, MAS
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Basel, Switzerland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Basel
Basel, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dolder PC, Holze F, Liakoni E, Harder S, Schmid Y, Liechti ME. Alcohol acutely enhances decoding of positive emotions and emotional concern for positive stimuli and facilitates the viewing of sexual images. Psychopharmacology (Berl). 2017 Jan;234(1):41-51. doi: 10.1007/s00213-016-4431-6. Epub 2016 Sep 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EKNZ 2014-369
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.